Wan Z, Wang X, Zhang X, Zhang X, Chen H
Department of General Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Department of Critical Care Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Transplant Proc. 2019 Apr;51(3):942-950. doi: 10.1016/j.transproceed.2019.01.060. Epub 2019 Jan 26.
Intrasplenic transplantation of xenogeneic hepatic oval cells (HOCs) may provide metabolic support for acute liver injury. However, xenoreactive lymphocyte-mediated immune response hinders HOCs' survival in the xeno-spleen parenchyma. Cytotoxic T-lymphocyte associated protein 4-Fas ligand (CTLA4.FasL), a fusion product integrating 2 inhibitory elements against lymphocytes into 1 molecule, effectively inhibited the proliferation of allogeneic and autoimmune lymphocytes. The purpose of this study was to explore the effect of CTLA4.FasL on the proliferation of xenoreactive lymphocytes and evaluate the therapeutic efficacy of CTLA4.FasL-modified HOC transplantation on acute liver injury in rats.
The effect of CTLA4.FasL-modified mouse liver epithelial progenitor cells (CTLA4.FasL-LEPCs) on the proliferation of rat lymphocytes in xeno-mixed lymphocyte reaction was investigated. Furthermore, CTLA4.FasL-LEPCs were intrasplenically transplanted in carbon tetrachloride- and partial hepatectomy-treated rats, and the therapeutic effect was evaluated using hematoxylin and eosin staining and alanine aminotransferase and aspartate aminotransferase assays. The hepatocytic differentiation of CTLA4.FasL-LEPCs in xenogeneic spleen was monitored by immunohistochemical staining for albumin.
In xeno-mixed lymphocyte reaction, CTLA4.FasL-LEPCs substantially inhibited the rat lymphocytes proliferation. CTLA4.FasL-LEPC transplantation significantly ameliorated liver injury compared with mCherry-modified LEPC and LEPC transplantation, as assessed by hematoxylin and eosin staining, alanine aminotransferase, and aspartate aminotransferase assays. Albumin positive cells appeared only in CTLA4.FasL-LEPCs group, but not in the mCherry-modified LEPCs group and LEPCs group.
Our results indicate CTLA4.FasL-LEPCs substantially improved liver function and structure in carbon tetrachloride- and partial hepatectomy-induced acute liver injury rats through long-term hepatocytic differentiation.
异种肝卵圆细胞(HOCs)脾内移植可为急性肝损伤提供代谢支持。然而,异种反应性淋巴细胞介导的免疫反应阻碍了HOCs在异种脾实质中的存活。细胞毒性T淋巴细胞相关蛋白4- Fas配体(CTLA4.FasL)是一种将2种针对淋巴细胞的抑制元件整合到1个分子中的融合产物,可有效抑制同种异体和自身免疫淋巴细胞的增殖。本研究旨在探讨CTLA4.FasL对异种反应性淋巴细胞增殖的影响,并评估CTLA4.FasL修饰的HOC移植对大鼠急性肝损伤的治疗效果。
研究CTLA4.FasL修饰的小鼠肝上皮祖细胞(CTLA4.FasL-LEPCs)在异种混合淋巴细胞反应中对大鼠淋巴细胞增殖的影响。此外,将CTLA4.FasL-LEPCs脾内移植到经四氯化碳和部分肝切除术处理的大鼠中,并通过苏木精-伊红染色以及丙氨酸氨基转移酶和天冬氨酸氨基转移酶检测评估治疗效果。通过白蛋白免疫组化染色监测CTLA4.FasL-LEPCs在异种脾中的肝细胞分化情况。
在异种混合淋巴细胞反应中,CTLA4.FasL-LEPCs显著抑制大鼠淋巴细胞增殖。苏木精-伊红染色、丙氨酸氨基转移酶和天冬氨酸氨基转移酶检测结果显示,与mCherry修饰的LEPC和LEPC移植相比,CTLA4.FasL-LEPC移植显著改善了肝损伤。白蛋白阳性细胞仅出现在CTLA4.FasL-LEPCs组,而mCherry修饰的LEPCs组和LEPCs组中未出现。
我们的结果表明,CTLA4.FasL-LEPCs通过长期的肝细胞分化显著改善了四氯化碳和部分肝切除术诱导的急性肝损伤大鼠的肝功能和结构。